Maximizing Outcomes in Relapsed/Refractory Multiple Myeloma: Tailoring Bispecific Antibody Approaches : Episode 6

Eva’s Treatment Journey with R/R MM

February 7, 2025

By Meera Mohan, MD
Areyl Goff, APNP

Opinion

Video

EP: 1.John’s Journey with R/R MM

EP: 2.Patient Education: Preparing Patients for Bispecific Treatment in R/R MM

EP: 3.Managing and Monitoring Infections and Neurological Toxicities in Patients Receiving Bispecific Therapies

EP: 4.Handling Dose Modifications and Treatment Interruptions Due to AEs With Bispecifics

EP: 5.Multidisciplinary Approaches to Managing AEs with Bispecifics

EP: 6.Eva’s Treatment Journey with R/R MM

EP: 7.Referring Patients on Bispecific Therapy: Initial Steps

EP: 8.Referral Process: Best Practices for Clear Communication

EP: 9.Referral Process With Bispecifics: Challenges and Support

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Recent Videos

Photo of a woman with blond wavy hair in front of a dark blue background

Photo of a man wearing a suit with a bowtie in front of an Oncology Nursing News backdrop

2 experts are featured in this series.

Latest Conference Coverage

Personalized Cancer Vaccines: Watching For Immune-Related, Vaccine AEs

Nurses, APPs Key to AE Management as T-Cell Engagers Move Into Solid Tumors

PI3K and AKT Inhibitor Toxicity Advice From a Breast Cancer Expert

Sonrotoclax/Zanubrutinib Generates Durable Response in R/R MCL

View More Latest Conference Coverage

Editorial Board

CancerNetwork.com

TargetedOnc.com

Terms & Conditions

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.